Versor Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-17,990
Closed -$1.57M – 269
2025
Q4
$1.57M Buy
17,990
+6,390
+55% +$485K 0.24% 65
2025
Q3
$664K Buy
+11,600
New +$668K 0.12% 235
2025
Q1
– Sell
-2,798
Closed -$231K – 812
2024
Q4
$231K Buy
+2,798
New +$221K 0.04% 656
2024
Q3
– Sell
-8,103
Closed -$555K – 852
2024
Q2
$555K Sell
8,103
-7,446
-48% -$445K 0.1% 322
2024
Q1
$834K Buy
+15,549
New +$836K 0.17% 183
2021
Q4
– Sell
-7,462
Closed -$572K – 582
2021
Q3
$572K Buy
7,462
+4,733
+173% +$380K 0.02% 226
2021
Q2
$212K Buy
+2,729
New +$194K 0.01% 318
2020
Q4
– Sell
-18,521
Closed -$917K – 182
2020
Q3
$917K Buy
+18,521
New +$955K 0.08% 81
2020
Q2
– Sell
-6,654
Closed -$283K – 247
2020
Q1
$283K Buy
+6,654
New +$329K 0.02% 185

Other funds holding GMED

Versor Investments's GMED Position: Q1 2026 in Review

Versor Investments sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 17,990 shares — an estimated $1.57M sold.

Versor Investments first reported a position in GMED in Q1 2020 and held it in 9 quarters. The position peaked at $1.57M in Q4 2025. 610 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Versor Investments reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 17,990 Globus Medical shares in Q1 2026, an estimated $1.57M.
  • Versor Investments first reported a position in Globus Medical in Q1 2020 and held it in 9 quarters.
  • Versor Investments's Globus Medical position peaked at $1.57M in Q4 2025.
  • 610 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.